Latest news
Fit to fund: UK biotech VC investment surges to five-year high - BioXconomyBioXconomy · Fri, 07 Aug 2026 10:51:38 GMTAttovia raises $265m in upsized IPO for trials - BioXconomyBioXconomy · Fri, 07 Aug 2026 07:59:22 GMTBraveheart Bio prices IPO at $18 per share - BioXconomyBioXconomy · Thu, 06 Aug 2026 20:37:06 GMTFDA committee approves loosening peptide regulation despite own evidence - BioXconomyBioXconomy · Tue, 04 Aug 2026 16:35:58 GMT